There are several types of mutations that can occur in the EGFR gene. The most common mutations include exon 19 deletions and the L858R point mutation in exon 21. These mutations are particularly prevalent in non-small cell lung cancer (NSCLC). Mutations in the EGFR gene can lead to constitutive activation of the receptor, promoting oncogenic signaling pathways.
